- Home
- AUPH vs NMZ Comparison
AUPH vs NMZ Comparison
Compare AUPH & NMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | NMZ |
|---|---|---|
| Founded | 1993 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUPH | NMZ |
|---|---|---|
| Price | $16.73 | $9.02 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.86 | N/A |
| AVG Volume (30 Days) | 737.0K | ★ 1.6M |
| Earning Date | 11-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.08% |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $15.83 | N/A |
| Revenue Next Year | $21.30 | N/A |
| P/E Ratio | $31.62 | ★ N/A |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $11.48 | $8.69 |
| 52 Week High | $19.25 | $10.77 |
Technical Indicators
Market Signals| Indicator | AUPH | NMZ |
|---|---|---|
| Relative Strength Index (RSI) | 57.21 | N/A |
| Support Level | $15.61 | N/A |
| Resistance Level | $17.02 | N/A |
| Average True Range (ATR) | 0.40 | 0.00 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 68.77 | 0.00 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About NMZ Nuveen Municipal High Income Opportunity Fund $0.01 par value per share
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The Fund's primary investment objective is to provide high current income exempt from regular federal income tax. The Fund's secondary investment objective is to seek an attractive total return consistent with its primary objective.